Ładuje się......
Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses
Fifteen monoclonal antibodies (mAbs) are currently registered and approved for the treatment of a range of different cancers. These mAbs are specific for a limited number of targets (9 in all). Four of these molecules are indeed directed against the B-lymphocyte antigen CD20; 3 against human epiderm...
Zapisane w:
| 1. autor: | |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Landes Bioscience
2013
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3827071/ https://ncbi.nlm.nih.gov/pubmed/24251081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.26333 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|